Tezosentan, another selective selection for pulmonary hypertension, or not?

Angela Lorts; Thomas P. Shanley

doi:10.1097/01.PCC.0000137989.92106.19

Tezosentan, another selective selection for pulmonary hypertension, or not?

Pediatrics

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	586-588
Number of pages	3
Journal	Pediatric Critical Care Medicine
Volume	5
Issue number	6
DOIs	https://doi.org/10.1097/01.PCC.0000137989.92106.19
State	Published - Dec 1 2004

Keywords

Endothelin receptor antagonism
Endothelin-1
Pulmonary hypertension
Selective pulmonary vasodilation

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health
Critical Care and Intensive Care Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1097/01.PCC.0000137989.92106.19

Cite this

@article{270b40a579a54547838c032c901bfafd,

title = "Tezosentan, another selective selection for pulmonary hypertension, or not?",

keywords = "Endothelin receptor antagonism, Endothelin-1, Pulmonary hypertension, Selective pulmonary vasodilation",

author = "Angela Lorts and Shanley, \{Thomas P.\}",

year = "2004",

month = dec,

day = "1",

doi = "10.1097/01.PCC.0000137989.92106.19",

language = "English (US)",

volume = "5",

pages = "586--588",

journal = "Pediatric Critical Care Medicine",

issn = "1529-7535",